Suicide warning for all antidepressants nAll antidepressants are to include a warning of the risk of suicide in their product information, the MHRA says. nThe requirement formerly applied only to SSRIs but, following a US review of safety data, the Agency says the risk is similar for all classes of antidepressants. nPatients at increased risk include young people with psychiatric morbidity and those with a history of suicidal ideation. Patients are at increased risk of suicide until remission occurs, and clinical experience shows that the risk is increased during the early stages of recovery.
展开▼
